Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Te… (NCT07316712) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Effect of TECAR (Transfer of Energy Capacitive and Resistive) Therapy on Chronic Supraspinatus Tendinitis
Egypt46 participantsStarted 2025-12-30
Plain-language summary
This study aims to investigate the effect of TECAR therapy on pain, shoulder range of motion, functional disability, and handgrip strength in patients with grade II supraspinatus tendinitis.
Who can participate
Age range30 Years – 55 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Supraspinatus Tendinitis grade II based on Neer's classification, confirmed by special tests, signs, and symptoms of grade I and II Supraspinatus Tendinitis for the past month, and taking non-steroidal anti-inflammatory drugs as suggested by the physician.
* All patients will have a body mass index between 18.5 and 29.9 kg/m².
Exclusion Criteria:
* Other grades of Supraspinatus Tendinitis.
* Any past shoulder surgical interventions.
* Instability of the shoulder joint due to other reasons, Acromioclavicular Joint Arthritis.
* Non-cooperative subjects.
* Diabetes
* Pregnant or lactating women.
* Serious neuromuscular or cardiovascular diseases.
* Systemic illness and severe COVID-19 cases will be excluded from this study.
* Pacemakers
* Heat Sensitivity
* Metal Implants
What they're measuring
1
Assessment of Pain Intensity of Shoulder Joint by Numerical Rating Scale (NRS)